Note: All prices and reports are based on end of the day (EOD) data.
Dishman Carbogen Amcis Limited (DCAL)
What DCAL does

Dishman Carbogen Amcis Limited

What company does?Pharmaceutical services and manufacturing
Established2007
Entity typePrivate
HeadquartersSwitzerland
SegmentB2B
Dishman Carbogen Amcis Limited is a share market listed company in the Healthcare industry . It got listed on NSE on 21-SEP-2017 under the trading symbol DCAL. On BSE it is listed under trading symbol DCAL. The company operates in Pharmaceuticals , Chemical Manufacturing and Contract Research & Development Services categories.

Company overview

Dishman Carbogen Amcis Limited is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, manufacturing, and packaging services. The company specializes in the production of high potency active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms.

With state-of-the-art facilities in India, Switzerland, UK, and China, Dishman Carbogen Amcis provides innovative solutions for drug development and commercialization. Their comprehensive service offerings encompass process research and development, custom synthesis, cGMP manufacturing of APIs and drug products as well as formulation development.

The company's expertise lies in handling complex chemistry to deliver challenging molecules at all scales. They cater to various therapeutic areas including oncology, metabolic disorders, inflammation/infectious diseases among others. This broad spectrum enables them to meet diverse client requirements efficiently.

Dishman Carbogen Amcis has also made significant strides in green chemistry by developing eco-friendly processes that minimize environmental impact without compromising quality or efficiency. This commitment aligns with their dedication towards sustainability. In terms of technological innovation, employs cutting-edge equipment for chemical synthesis such as hydrogenation reactors capable of handling high-pressure reactions often required during API manufacturing. The Company distinguishes itself through its strong focus on quality management systems which are compliant with international regulatory standards like USFDA & EDQM. Additionally, they have established strategic collaborations with renowned pharma companies globally ensuring access to advanced technologies & scientific expertise while enhancing their market presence. Overall,Dishman Carbogen Amcis continues to set itself apart from competitors through its robust infrastructure,dynamic R&D capabilities,and unwavering commitment toward sustainable practices along with fostering partnerships that drive continued growth within the pharmaceutical sector.

Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.